Emcure Pharmaceuticals Limited — Amphotericin Exporter Profile
Indian Pharmaceutical Exporter · #3 for Amphotericin · $4.5M export value · DGFT Verified
Emcure Pharmaceuticals Limited is the #3 Indian exporter of Amphotericin with $4.5M in export value and 89 verified shipments. Emcure Pharmaceuticals Limited holds a 5.1% market share in Amphotericin exports across 7 countries. The company exports 39 pharmaceutical products worth $147.8M across 19 therapeutic categories.
Emcure Pharmaceuticals Limited — Amphotericin Export Profile: Buyers & Destinations
Where Does Emcure Pharmaceuticals Limited Export Amphotericin?
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED KINGDOM | $1.3M | 49 | 61.0% |
| MALTA | $400.6K | 16 | 19.5% |
| OMAN | $300.0K | 12 | 14.6% |
| UNITED ARAB EMIRATES | $50.0K | 1 | 2.4% |
| CHILE | $50.0K | 1 | 2.4% |
| BRAZIL | $48 | 1 | 0.0% |
| GERMANY | $26 | 9 | 0.0% |
Emcure Pharmaceuticals Limited exports Amphotericin to 7 countries. The largest destination is UNITED KINGDOM accounting for 61.0% of Emcure Pharmaceuticals Limited's Amphotericin shipments, followed by MALTA (19.5%) and OMAN (14.6%). These destinations reflect Emcure Pharmaceuticals Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Amphotericin from Emcure Pharmaceuticals Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| TILLOMED LABORATORIES LTD | UNITED KINGDOM | $550.0K | 13 |
| TILLOMED LABORATORIES LTD ,,, | UNITED KINGDOM | $400.0K | 16 |
| TILLOMED MALTA LTD | MALTA | $350.0K | 12 |
| TILLOMED LABORATORIES LIMITED | UNITED KINGDOM | $300.4K | 20 |
| MUSCAT PHARMACY & STORE LLC | OMAN | $150.0K | 6 |
| MUSCAT PHARMACY & STORE LLC. | OMAN | $100.0K | 4 |
| MUSCAT PHARMACY STORE LLC | OMAN | $50.0K | 2 |
| ROYAL PHARMACEUTICAL DRUGS STORE L. | UNITED ARAB EMIRATES | $50.0K | 1 |
| TILLOMED MALTA LIMITED | MALTA | $50.0K | 2 |
| EMCURE PHARMA CHILE S.P.A. | CHILE | $50.0K | 1 |
Emcure Pharmaceuticals Limited supplies Amphotericin to 13 buyers globally. The largest buyer is TILLOMED LABORATORIES LTD (UNITED KINGDOM), followed by TILLOMED LABORATORIES LTD ,,, (UNITED KINGDOM) and TILLOMED MALTA LTD (MALTA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Amphotericin Export Value and How Much Does Emcure Pharmaceuticals Limited Contribute?
India exported $28.0M worth of Amphotericin through 1,226 shipments from 180 suppliers to 116 countries, serving 390 buyers globally. Emcure Pharmaceuticals Limited contributes $4.5M to this total, accounting for 5.1% of India's Amphotericin exports. Emcure Pharmaceuticals Limited ships Amphotericin to 7 countries through 13 buyers.
What Is the Average Shipment Value for Emcure Pharmaceuticals Limited's Amphotericin Exports?
Emcure Pharmaceuticals Limited's average Amphotericin shipment value is $50.0K per consignment, based on 89 shipments totaling $4.5M. The largest destination is UNITED KINGDOM (61.0% of Emcure Pharmaceuticals Limited's Amphotericin exports).
How Does Emcure Pharmaceuticals Limited Compare to Other Indian Amphotericin Exporters?
Emcure Pharmaceuticals Limited ranks #3 among 180 Indian Amphotericin exporters with a 5.1% market share. The top 3 exporters are BHARAT SERUMS AND VACCINES LIMITED ($15.8M), EMCURE PHARMACEUTICALS LIMITED ($4.5M), SUN PHARMACEUTICAL INDUSTRIES LIMITED ($3.8M). Emcure Pharmaceuticals Limited processed 89 shipments to 7 destination countries.
What Amphotericin Formulations Does Emcure Pharmaceuticals Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| AMPHOTERICIN B LIPOSOME FOR INJECTION,50MG/VIAL | $350.0K | 9 |
| Medicines Amphotericin B Liposome for Injection,50MG/VIAL BATCH NO: ES250079A MFG DT: JAN 2025 EXP DT: DEC 2027 (10'S PA | $200.0K | 4 |
| PHARMACEUTICALS PRODUCTS(FINISHED PRODUCT): TRASPOR 50 MG INJ 1 VIAL( LIPOSOMALAMPHOTERICIN-B INJECTION 50 MG) | $100.0K | 2 |
| (MEDICINES) AMPHOTERICIN B LIPOSOME FORINJECTION,50MG/VIAL | $100.0K | 3 |
| PHARMA: TRASPOR 50MG INJECTION (LIPOSOMAL AMPHOTERICIN-B INJECTION 50MG)-1 VIAL(INV.NO.:2312300632 DT. 31.12.2023)VLS | $50.0K | 1 |
| MEDICINES Liposomal Amphotericin BInjection, 50 mg/via : BATCH NO. : ES240353A , MFG: Nov 2024 , EXP: Oct 20 | $50.0K | 2 |
| MEDICINES Liposomal Amphotericin B Injection, 50 mg/via : BATCH NO.: ES240367A , MFG: Nov 2024 , EXP: Oct 2 | $50.0K | 2 |
| MEDICINES AMPHOTERICIN B LIPOSOMAL FOR INJ.50 MG BATCH NO. ES240052A, MFGJUN 2023 EXP MAY 2026 (PACKS) | $50.0K | 1 |
| PHARMACEUTICAL PRODUCTS: TRASPOR 50 MG INJ 1 VIAL (LIPOSOMAL AMPHOTERICIN-B INJECTION 50 MG) | $50.0K | 1 |
| PHARMA: TRASPOR 50MG INJECTION (LIPOSOMAL AMPHOTERICIN-B INJECTION 50MG)(LYOPHILIZED)-1VIAL (I.NO.2403300907/30.03.2024) | $50.0K | 1 |
Emcure Pharmaceuticals Limited exports 59 distinct Amphotericin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is AMPHOTERICIN B LIPOSOME FOR INJECTION,50MG/VIAL with 9 shipments worth $350.0K.
Regulatory Requirements: Exporting Amphotericin to Key Markets
What Emcure Pharmaceuticals Limited must comply with to export Amphotericin to its top destination countries
United Kingdom — MHRA
Approval Process
Post-Brexit UK Marketing Authorisation via national procedure. Separate from EU approval since January 2021.
Timeline: 12–15 months
GMP & Export Requirements
UK GMP compliance; MHRA inspection of manufacturing site
Manufacturer Import Authorisation (MIA) held by UK importer; Qualified Person (QP) batch release
Note: Post-Brexit: EU GMP certificates no longer automatically valid in UK. Separate MHRA recognition required.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Emcure Pharmaceuticals Limited Compare to Nearest Amphotericin Exporters?
Exporters ranked immediately above and below #3 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | BHARAT SERUMS AND VACCINES LIMITED | $15.8M | 315 | 47 | $50.0K |
| 3 | EMCURE PHARMACEUTICALS LIMITED ★ | $4.5M | 89 | 7 | $50.0K |
| 2 | SUN PHARMACEUTICAL INDUSTRIES LIMITED | $3.8M | 76 | 6 | $50.0K |
| 8 | CIPLA LIMITED | $750.0K | 15 | 4 | $50.0K |
Emcure Pharmaceuticals Limited ranks #3 among 180 Indian Amphotericin exporters. Average shipment value of $50.0K compared to the market average of $155.4K. The closest competitors by value are BHARAT SERUMS AND VACCINES LIMITED and SUN PHARMACEUTICAL INDUSTRIES LIMITED.
Which Indian Ports Ship Amphotericin Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 352 | 28.7% |
| SAHAR AIR | 345 | 28.1% |
| Bombay Air | 119 | 9.7% |
| DELHI AIR | 65 | 5.3% |
| DELHI AIR CARGO ACC (INDEL4) | 62 | 5.1% |
| NHAVA SHEVA SEA (INNSA1) | 38 | 3.1% |
| Bombay Air Cargo | 31 | 2.5% |
| BANGALORE ACC (INBLR4) | 20 | 1.6% |
Geopolitical & Trade Policy Impact on Emcure Pharmaceuticals Limited's Amphotericin Exports
Emcure's extensive export operations are influenced by various geopolitical factors. The Israel-Iran tensions have led to disruptions in Red Sea shipping routes, increasing shipping costs and transit times for Indian exporters. This situation necessitates strategic adjustments in logistics and supply chain management to mitigate potential delays and cost escalations.
Conversely, the ongoing US-China trade tensions have opened opportunities for Indian pharmaceutical companies like Emcure to expand their footprint in the US market. The US's inclination to diversify its supply chain away from China presents a favorable environment for Indian exporters to increase their market share.
In the European Union, stringent regulatory changes, such as the Falsified Medicines Directive, impose additional compliance requirements on exporters. Emcure's adherence to these regulations is crucial for maintaining and expanding its presence in the EU market.
Emcure Pharmaceuticals Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards is paramount for Emcure's export operations. The company has consistently met the Good Manufacturing Practice (GMP) requirements set by the FDA, WHO, and EU authorities. However, the evolving regulatory landscape demands continuous investment in quality assurance and compliance mechanisms to ensure uninterrupted market access.
Recent incidents, such as the brief shutdown of the Pune plant due to a fire, highlight the importance of robust risk management and compliance strategies to maintain operational continuity and regulatory adherence. (tipranks.com)
About Emcure Pharmaceuticals Limited
Emcure Pharmaceuticals Limited exports 39 products worth $147.8M. Beyond Amphotericin, top products include Dolutegravir, Mycophenolate, Tenofovir, Iron, Melphalan. View the complete Emcure Pharmaceuticals Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Amphotericin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Amphotericin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Emcure Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 89 individual customs records matching Emcure Pharmaceuticals Limited exporting Amphotericin, covering 59 formulations to 7 countries via 13 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 116+ countries, 390+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Amphotericin Export Data from Emcure Pharmaceuticals Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Emcure Pharmaceuticals Limited's Amphotericin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Emcure Pharmaceuticals Limited
Full Company Profile →
39 products · $147.8M total trade · 19 categories
Amphotericin Stats
Company Overview
Top Products by Emcure Pharmaceuticals Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Emcure Pharmaceuticals Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Amphotericin. For current shipment-level data, contact TransData Nexus.